跳至主要内容
临床试验/CTRI/2018/02/012074
CTRI/2018/02/012074尚未招募未知

Observational, Non-invasive study to measure the Vital signs and Fingerstick Blood Glucose levels using the LifeLeaf Wristwatch

ifePlus0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • I.Adults aged 18-90 years and above who are either healthy adults, or
  • II.Carry diagnosis of Type 2 diabetes, high blood pressure, some form cardiac arrhythmia, and/or chronic obstructive pulmonary disease (COPD) (subjects with combinations of these conditions can also be included).
  • Group B: Subject should have history of at least one active cardiac arrhythmia including atrial fibrillation, atrial flutter/fibrillation, bigeminy / trigeminy, various types of heart block (first-degree, second-degree, third-degree), or other paroxysmal or sustained tachy- or brady-arrhythmias (other than sinus tachycardia or sinus bradycardia)
  • Group C: Subject should have known history of restrictive or obstructive airway/lung diseases such as interstitial lung disease, COPD, asthma or bronchitis

排除标准

  • I.Patients not willing to give consent to participate in the study
  • II.Females of childbearing potential, who are neither surgically sterilized nor willing to use reliable contraceptive methods (double barrier methods or intrauterine device), unless they affirm that they are celibate and are willing to remain celibate for the duration of the study and to also have urinary hCG test (pregnancy test) checked on the morning of each study visit with result coming back negative for pregnancy prior to proceeding with the study visit.
  • III.Pregnant or lactating women.
  • IV.In the opinion of the investigator, subject is unable to cooperate with any study procedures, unlikely to adhere to the study procedures, keep appointments, or plan to relocate during the study.
  • V. Inability to do light walking for up to 10 minutes;
  • VI. Inability to safely fast from midnight until noon (may drink water);
  • VII.History of Diabetic Ketoacidosis or Hyperosmolar Nonketotic Coma;
  • VIII.Sufficiently â??brittleâ?? diabetes where remaining off of diabetic medications (injectable insulin or oral medications) for the durations of the study visits would be deemed to pose a health concern;
  • IX.Most recently checked HbA1c >12.0;
  • X.Congestive heart failure (given that subjects will be administered fluids containing sodium for this initial study);
  • XI.Have a pacemaker or implantable cardioverter defibrillator;
  • XII.History of significant peripheral vascular disease in the upper extremities including stents, bypasses, or arteriovenous grafts involving arteries of the upper extremities, history of claudication in the upper extremities, or other circumstances that would preclude safely or reliably obtaining cuff BP in the left arm;
  • XIII.End-stage renal disease, hyperkalemia, cardiac arrhythmia, or patients taking medications or adhering to specific dietary regimens for the purposes of lowering potassium levels.
  • XIV.Any circumstances where consumption of two 591.5 mL bottles of Gatorade per visit would be deemed to be acutely and significantly deleterious to a subjectâ??s immediate health from the standpoints of sodium, potassium, and sugar intake.

研究者

发起方
ifePlus

相似试验